Document is current
Any future updates will be listed below
-
Authors
Cortellino, S. https://orcid.org/0000-0001-8331-3800
Quagliariello, V.
Delfanti, G.
Blaževitš, O.
Chiodoni, C. https://orcid.org/0000-0002-7644-9969
Maurea, N.
Di Mauro, A.
Tatangelo, F. https://orcid.org/0000-0002-9943-6079
Pisati, F.
Shmahala, A.
Lazzeri, S.
Spagnolo, V.
Visco, E.
Tripodo, C. https://orcid.org/0000-0002-0821-6231
Casorati, G. https://orcid.org/0000-0002-5102-4112
Dellabona, P. https://orcid.org/0000-0002-1414-633X
Longo, V. D. https://orcid.org/0000-0002-0946-7534
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (17605, 21820)
- License Information
-
More Information
Article History
Received: 8 November 2022
Accepted: 22 August 2023
First Online: 8 September 2023
Competing interests
: V.D.L. holds intellectual property rights on clinical uses of FMD and equity interest in L-Nutra, a company that markets medical food. The remaining authors declare no competing interests.
